Lucas CP, Boldrin MN, Reaven GM
Traditionally, this combination has been used to support mucosal comfort in cases of occasional heartburn, digestive irritation, and post-antibiotic recovery
If insulin therapy is decided upon, single doses of basal insulin, preferably a long-acting analogue, are recommended
Addressing Current Gaps and Unmet Needs GLP-1R agonists have rapidly evolved from glucose-lowering agents for T2DM to multifaceted therapeutics with FDA- and EMA-approved indications for obesity, cardiovascular disease, chronic kidney disease, diabetic nephropathy, and sleep apnea
2023;37:e23267
Despite the appetite-suppressing effects of GLP-1 medications, some patients continue to experience sugar cravings, which can be confusing and frustrating